ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter (OTC) cold remedy and consumer products, natural base health products, and other supplements and cosmeceuticals in the United States.
Founded in 1989, the Company is headquartered in Doylestown, Pennsylvania. ProPhase Labs’ stock is traded on the Nasdaq Global Market (NasdaqGM: PRPH).
Our mission is to develop and market remedies that offer pioneering new options to improve treatment results. We develop and acquire high performance homeopathic and allopathic compounds and offer unique methods to deliver those compounds. Our core objective is to address the root cause of symptoms and conditions with the goal of exceeding the efficacy and safety of current treatment options.
Our ongoing objective is to deliver long-term value to our consituents by providing exceptional new products that address the health care and quality of life concerns of the broadest market segments
Simply put, we utilize cutting-edge science to change lives.
ProPhase Labs has several business units. They include: